HIV1 serology; HIV1 antibody (HIV1 EIA/ELISA, immunoblot)

From Aaushi
Jump to navigation Jump to search

Indications

Methods

EIA is the most common method for screening individuals & blood products for antibodies to HIV. Antibodies usually appear by week 4-12 of infection, but seronegativity may be prolonged. Additionally, antibodies may diminish as the disease process progresses. Thus a negative EIA does not rule out disease.

EIA's for HIV are 99+% sensitive for antibody to the virus, but false positives may occur with specimens that are RPR positive or from patients with hemophilia or on dialysis. EIA is generally done in duplicate & duplicate negatives are considered negative. Positive EIA's are confirmed by western blot.

Specimen

More general terms

More specific terms

Additional terms

Component of

References

  1. Clinical Guide to Laboratory Tests, 3rd edition, NW Tietz ed, WB Saunders, Philadelphia, 1995
  2. HIV-1 Antibody Confirm, Western Blot Laboratory Test Directory ARUP: http://www.aruplab.com/guides/ug/tests/0020284.jsp
  3. HIV-1 Antibody Laboratory Test Directory ARUP: http://www.aruplab.com/guides/ug/tests/0000000.jsp

Patient information

HIV1 serology patient information